In summary, the potential mechanism by which GALNT5 affects FOLFIRINOX chemotherapy resistance in pancreatic cancer may be that it affects the HR repair process of DSB during chemotherapy. The gene discussed is GALNT5; the disease is pancreatic neoplasm.